Bio-Techne (TECH) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Bio-Techne · Health Care · ref. ETF XLV · 50 calls · price $72.47
What the company does: Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.
📈 Bio-Techne (TECH) stock price
$72.47+33.4% over range
Aug 28, 25low $43.3 · high $72.48Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
0% recommend buying · 10 analysts
📊 JPI status : Bio-Techne has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 TECH price target & analyst consensus — price $72.47
The price target · all analysts combined (8 targets)
Highest target · 6 firms of 8$73+0.7%
Median target · of 8 targets$73+0.7%
Lowest target · 1 firm of 8$50-31.0%
Current price$72.47
Where these 8 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
675%
$73
Below
225%
$50 ↔ $65
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Stephens & Co. — 68% of its targets hit on this sector (99 calls tested). It aims for $73 (+0.7 %), call made on June 27, 2026, maturing on June 27, 2027 (62 d ago).
The 6 reliable analysts
$73+0.7 %
The 2 other firms
$61.50-15 %
How to read it: the 6 reliable firms are not filtered by optimism — 5 aim above the price, 1 below, hence their $73 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 10 ratings (last 6 months)
Strong Buy00%
Buy00%
Hold10100%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 TECH price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on TECH most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in TECH? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Bio-Techne? The JPI assistant answers using our backtest data.
💰 Bio-Techne dividend: yield, history & growth › open the full page
0.45%annual yield
That's ~$0.32 per share per year.
📈 Bio-Techne fundamentals: valuation, margins & growth › open the full page
P/E 62.5Net margin 15.0 %Revenue growth +1.3 %Very high P/E
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2023
marg. 25 %
2024
Rev +2%Profit −41%
2025
Rev +5%Profit −56%
2026
Rev −0%Profit +148%
🔎 Detailed analyses
✅ Historical analyst reliability on TECH
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Stifel ↗ | 100% | +55.2% | 5 |
| Janney Montgomery Scott | 100% | +17.8% | 2 |
| Craig-Hallum ↗ | 100% | +13.5% | 2 |
| Wells Fargo ↗ | 100% | +12.5% | 3 |
| Citigroup ↗ | 83% | +21.7% | 6 |
| Deutsche Bank ↗ | 67% | +22.8% | 6 |
| Stephens & Co. ↗ | 50% | +10.9% | 8 |
| Baird ↗ | 50% | +7.5% | 10 |
| UBS ↗ | 50% | -1.3% | 2 |
| SVB Leerink | 33% | +10.8% | 6 |
See the other 4 firms
| Keybanc ↗ | 20% | -8.1% | 5 |
| Benchmark ↗ | 29% | -3.6% | 7 |
| Argus Research ↗ | 33% | -1.2% | 3 |
| Scotiabank ↗ | 33% | +2.3% | 3 |
📊 What $1,000 invested in Bio-Techne would be worth › open the full page
In short — $1,000 invested in Bio-Techne 10 years ago would be worth $3,140 today, i.e. +12%/yr on average. Best year: 2021 (+63%), worst: 2022 (-36%). Price performance, excluding dividends.
If I'd invested $1,000 in Bio-Techne
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $981 | -2% |
| 3 years ago | $852 | -15% |
| 5 years ago | $890 | -11% |
Return by year (Bio-Techne)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +20% | $1,201 (+20%) |
| 2025 | -18% | $981 (-2%) |
| 2024 | -7% | $916 (-8%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Bio-Techne
Loading news…
📋 All analyst calls on TECH
Filtered on — · ✕ show all
Wells Fargo ↗
Aug 13, 26
■ Equal-Weight neutral · not a buy · 🎯$73
Price at call : $72.4 — gap to target +1%
Today : $72.47 — gap to target +1%
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Aug 13, 27
matures : Aug 13, 27
RBC Capital ↗
Jul 9, 26
■ Sector Perform neutral · not a buy · 🎯$73
Price at call : $71.3 — gap to target +2%
Today : $72.47 — gap to target +1%
🎯 on TECH : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
■ Hold neutral · not a buy · 🎯$73
Price at call : $71 — gap to target +3%
Today : $72.47 — gap to target +1%
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Jun 30, 27
matures : Jun 30, 27
■ Hold neutral · not a buy
🎯 on TECH : 33% (3 calls matureds) · 📊 on Health : 47.4% · -1.5% (19 calls)
in progress (365j)
matures : Jun 30, 27
matures : Jun 30, 27
■ Neutral neutral · not a buy · 🎯$73
Price at call : $70.9 — gap to target +3%
Today : $72.47 — gap to target +1%
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Jun 29, 27
matures : Jun 29, 27
Stephens & Co. ↗
Jun 26, 26
■ Equal-Weight neutral · not a buy · 🎯$73
Price at call : $70.9 — gap to target +3%
Today : $72.47 — gap to target +1%
🎯 on TECH : no call matured yet · 📊 on Health : 52.5% · +0.2% (99 calls)
in progress (365j)
matures : Jun 26, 27
matures : Jun 26, 27
William Blair ↗
Jun 26, 26
■ Market Perform neutral · not a buy
🎯 on TECH : no call matured yet · 📊 on Health : 63% · +5.2% (27 calls)
in progress (365j)
matures : Jun 26, 27
matures : Jun 26, 27
■ Neutral neutral · not a buy · 🎯$73
Price at call : $71 — gap to target +3%
Today : $72.47 — gap to target +1%
🎯 on TECH : 0% (3 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Jun 26, 27
matures : Jun 26, 27
See the other 42 calls, newest to oldest
Piper Sandler ↗
Jun 11, 26
■ Neutral neutral · not a buy · 🎯$65
Price at call : $54.02 — gap to target +20%
Today : $72.47 — gap to target -10%
🎯 on TECH : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Jun 11, 27
matures : Jun 11, 27
▲ Buy · 🎯$70
Price at call : $48.36 — upside +45%
Today : $72.47 — upside -3%
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
Wells Fargo ↗
May 7, 26
▲ Overweight · 🎯$62
Price at call : $48.36 — upside +28%
Today : $72.47 — upside -14%
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
Evercore ISI Group ↗
May 7, 26
■ In-Line neutral · not a buy · 🎯$50
Price at call : $48.36 — gap to target +3%
Today : $72.47 — gap to target -31%
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
Evercore ISI Group ↗
Apr 6, 26
■ In-Line neutral · not a buy · 🎯$54
Price at call : $53.83 — gap to target +0%
Today : $72.47 — gap to target -25%
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
Wells Fargo ↗
Feb 6, 26
▲ Overweight · 🎯$76
Price at call : $65.48 — upside +16%
Today : $72.47 — upside +5%
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▲ Buy · 🎯$80
Price at call : $66.78 — upside +20%
Today : $72.47 — upside +10%
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
■ Hold neutral · not a buy · 🎯$65
Price at call : $66.78 — gap to target -3%
Today : $72.47 — gap to target -10%
🎯 on TECH : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
▲ Buy · 🎯$80
Price at call : $66.78 — upside +20%
Today : $72.47 — upside +10%
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
▲ Buy · 🎯$79
Price at call : $66.78 — upside +18%
Today : $72.47 — upside +9%
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
Evercore ISI Group ↗
Feb 5, 26
■ In-Line neutral · not a buy · 🎯$68
Price at call : $66.78 — gap to target +2%
Today : $72.47 — gap to target -6%
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
Evercore ISI Group ↗
Jan 5, 26
■ In-Line neutral · not a buy · 🎯$62
Price at call : $65.28 — gap to target -5%
Today : $72.47 — gap to target -14%
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
Argus Research ↗
Nov 20, 25
▲ Buy · 🎯$68
Price at call : $58.73 — upside +16%
Today : $72.47 — upside -6%
🎯 on TECH : no call matured yet · 📊 on Health : 55.7% · +2.6% (158 calls)
in progress (365j)
matures : Nov 20, 26
matures : Nov 20, 26
▲ Buy · 🎯$70
Price at call : $57.41 — upside +22%
Today : $72.47 — upside -3%
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
Wells Fargo ↗
Nov 6, 25
▲ Overweight · 🎯$70
Price at call : $57.41 — upside +22%
Today : $72.47 — upside -3%
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Buy · 🎯$70
Price at call : $59.27 — upside +18%
Today : $72.47 — upside -3%
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Oct 14, 26
matures : Oct 14, 26
Evercore ISI Group ↗
Oct 7, 25
▲ Outperform · 🎯$72
Price at call : $60.56 — upside +19%
Today : $72.47 — upside -1%
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Oct 7, 26
matures : Oct 7, 26
RBC Capital ↗
Sep 3, 25
▲ Outperform · 🎯$73
Price at call : $52.92 — upside +38%
Today : $72.47 — upside +1%
🎯 on TECH : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Sep 3, 26
matures : Sep 3, 26
▲ Buy · 🎯$70
Price at call : $54 — upside +30%
Today : $72.47 — upside -3%
Expected +30% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
+33.9%
stock +34% · XLV +27%
matured Aug 21, 26
RBC Capital ↗
Aug 7, 25
■ Sector Perform neutral · not a buy · 🎯$61
Price at call : $50.42 — gap to target +21%
Today : $72.47 — gap to target -16%
🎯 on TECH : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Aug 7, 26
matures : Aug 7, 26
Scotiabank ↗
Jul 11, 25
▲ Sector Outperform · 🎯$75
Price at call : $52.62 — upside +43%
Today : $72.47 — upside +3%
Expected +43% · Actual +36% · Reason (≥ +15%) : ✓ Yes
🎯 on TECH : 33% (3 calls matureds) · 📊 on Health : 33.3% · -8.8% (9 calls)
+35.6%
stock +36% · XLV +20%
matured Jul 11, 26
▲ Buy · 🎯$65
Price at call : $52.59 — upside +24%
Today : $72.47 — upside -10%
Expected +24% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 49% · +1.0% (96 calls)
+35.3%
stock +35% · XLV +20%
matured Jul 9, 26
▲ Buy · 🎯$75
Price at call : $48.69 — upside +54%
Today : $72.47 — upside +3%
Expected +54% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 33% (3 calls matureds) · 📊 on Health : 47.4% · -1.5% (19 calls)
+8.1%
stock +8% · XLV +14%
matured Jun 5, 26
Wells Fargo ↗
May 30, 25
▲ Overweight · 🎯$59
Price at call : $48.4 — upside +22%
Today : $72.47 — upside -19%
Expected +22% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
+4.9%
stock +5% · XLV +11%
matured May 30, 26
▲ Buy · 🎯$70
Price at call : $53.9 — upside +30%
Today : $72.47 — upside -3%
Expected +30% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 51.5% · +3.1% (355 calls)
-12.0%
stock -12% · XLV +5%
matured May 10, 26
RBC Capital ↗
May 8, 25
■ Sector Perform neutral · not a buy · 🎯$63
Price at call : $49.94 — gap to target +26%
Today : $72.47 — gap to target -13%
🎯 on TECH : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : May 8, 26
matures : May 8, 26
▲ Buy · 🎯$75
Price at call : $49.94 — upside +50%
Today : $72.47 — upside +3%
Expected +50% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 33% (3 calls matureds) · 📊 on Health : 47.4% · -1.5% (19 calls)
-5.1%
stock -5% · XLV +8%
matured May 8, 26
■ Hold neutral · not a buy · 🎯$60
Price at call : $49.94 — gap to target +20%
Today : $72.47 — gap to target -17%
🎯 on TECH : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : May 8, 26
matures : May 8, 26
■ Sector Weight neutral · not a buy
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 44.1% · -1.7% (143 calls)
in progress (365j)
matures : Apr 9, 26
matures : Apr 9, 26
■ Sector Weight neutral · not a buy
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 44.1% · -1.7% (143 calls)
in progress (365j)
matures : Apr 8, 26
matures : Apr 8, 26
Evercore ISI Group ↗
Mar 18, 25
▲ Outperform · 🎯$75
Price at call : $62.83 — upside +19%
Today : $72.47 — upside +3%
Expected +19% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
-19.1%
stock -19% · XLV +0%
matured Mar 18, 26
■ Neutral neutral · not a buy · 🎯$70
Price at call : $62.2 — gap to target +13%
Today : $72.47 — gap to target -3%
🎯 on TECH : 100% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Mar 4, 26
matures : Mar 4, 26
■ Neutral neutral · not a buy · 🎯$68
Price at call : $65.8 — gap to target +3%
Today : $72.47 — gap to target -6%
🎯 on TECH : 0% (3 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Feb 19, 26
matures : Feb 19, 26
RBC Capital ↗
Feb 6, 25
■ Sector Perform neutral · not a buy · 🎯$80
Price at call : $72.81 — gap to target +10%
Today : $72.47 — gap to target +10%
🎯 on TECH : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Feb 6, 26
matures : Feb 6, 26
Scotiabank ↗
Feb 6, 25
▲ Sector Outperform · 🎯$90
Price at call : $72.81 — upside +24%
Today : $72.47 — upside +24%
Expected +24% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 33% (3 calls matureds) · 📊 on Health : 33.3% · -8.8% (9 calls)
-10.1%
stock -10% · XLV +7%
matured Feb 6, 26
▲ Overweight · 🎯$90
Price at call : $72.81 — upside +24%
Today : $72.47 — upside +24%
Expected +24% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 0% (1 call matured) · 📊 on Health : 44.1% · -1.7% (143 calls)
-10.1%
stock -10% · XLV +7%
matured Feb 6, 26
▲ Outperform · 🎯$88
Price at call : $75.01 — upside +17%
Today : $72.47 — upside +21%
Expected +17% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 0% (3 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-11.0%
stock -11% · XLV +7%
matured Feb 6, 26
Scotiabank ↗
Oct 31, 24
▲ Sector Outperform · 🎯$88
Price at call : $75.31 — upside +17%
Today : $72.47 — upside +21%
Expected +17% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 33% (3 calls matureds) · 📊 on Health : 33.3% · -8.8% (9 calls)
-18.7%
stock -19% · XLV -2%
matured Oct 31, 25
▲ Outperform · 🎯$84
Price at call : $73.75 — upside +14%
Today : $72.47 — upside +16%
Expected +14% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 0% (3 calls matureds) · 📊 on Health : 51.7% · +6.5% (298 calls)
-15.2%
stock -15% · XLV -2%
matured Oct 31, 25
▲ Buy · 🎯$95
Price at call : $72.75 — upside +31%
Today : $72.47 — upside +31%
Expected +31% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on TECH : 33% (3 calls matureds) · 📊 on Health : 47.4% · -1.5% (19 calls)
-26.1%
stock -26% · XLV -12%
matured Aug 13, 25
RBC Capital ↗
Aug 8, 24
■ Sector Perform neutral · not a buy · 🎯$70
Price at call : $71.77 — gap to target -2%
Today : $72.47 — gap to target -3%
🎯 on TECH : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Aug 8, 25
matures : Aug 8, 25
Frequently asked questions
Should I buy Bio-Techne stock?
This isn't buy advice. For Bio-Techne, the analyst consensus is "Hold", with an average price target of $73.00 (+1% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (5 calls tracked on Bio-Techne). We show the numbers — you decide.
Is it too late to buy Bio-Techne? How high can it go?
The most bullish analyst target on Bio-Techne is $73.00 (+1% above today's price); the average is $73.00. That's the upside they see. Check how reliable those analysts have actually been on Bio-Techne on our site before trusting it.
Is Bio-Techne still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 14 analysts have a real record on Bio-Techne, the best hitting 100% over 5 calls. Current consensus: "Hold". Make your call on data, not noise.
Should you invest in Bio-Techne? The case for and against
The arguments for and against, one by one, from the numbers: why invest in TECH (and why hesitate).
What has Bio-Techne's past performance been?
Historical returns and a "how much if I had invested" calculator: TECH performance & returns.
Does Bio-Techne pay a dividend?
Yield, consistency and growth history of the dividend: TECH's dividend.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX